drugset / Trial / NCT00553293
Nordic Luveris Study
Phase 4
Completed
526 enrolled
Rigshospitalet, Denmark
Helse Fonna · collabHerlev Hospital · collabHolbaek Sygehus · collabHvidovre University Hospital · collabKarolinska University Hospital · collabOdense University Hospital · collabRegionshospitalet Viborg, Skive · collabTurku Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | recombinant luteinizing hormone | Protein / enzyme biologic | 75 iu | — |
| Comparator | Gonal-f | Protein / enzyme biologic | 150 iu | — |